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ABSTRACT
Emphysematous hepatitis is a rare entity characterized by the replacement of hepatic parenchyma by gas, leading to acute liver failure. Often 
it occurs in patients with diabetes mellitus, liver disease or a recent history of abdominal surgery. We present a case of emphysematous 
hepatitis in a 74-year-old man with no recognizable risk factors. Despite the early broad-spectrum antimicrobial therapy and supportive 
care, the condition progressed to a fatal outcome, as seen in other case reports. Early recognition of this condition and rapid and aggressive 
management may improve patient outcomes.
LEARNING POINTS
• Emphysematous hepatitis is a rare condition characterized by replacement of hepatic parenchyma by gas.
• The diagnosis of emphysematous hepatitis requires imaging, preferably a computed tomography scan.
• Emphysematous hepatitis warrants awareness among clinicians for early diagnosis and rapid and aggressive management.
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CASE PRESENTATION
A 74-year-old man was admitted to the emergency department (ED) of our hospital with altered mental status. He complained of fever, 
cough with mucopurulent sputum, and abdominal pain for 2 days. He had a medical history of hypertension, gastroesophageal reflux, and 
moderate alcohol consumption. His usual medication was lansoprazole 20 mg daily, perindopril 5 mg daily, and amlodipine 5 mg daily, with no 
known medical allergies. On examination, he was disoriented and uncooperative. His vital signs included blood pressure of 135/85 mmHg, 
heart rate of 103 beats/min, respiratory frequency of 18 breaths/min, peripheral oxygen saturation of 85% on room air, and tympanic 
temperature of 39.6 ºC. His skin showed signs of livedo reticularis and his capillary refill time was increased. Pulmonary auscultation 
showed bilateral rhonchi. On abdominal palpation, he complained of intense epigastric and right hypochondrium pain with muscle guarding. 
Laboratory examination revealed hypoxic respiratory failure, leukocytosis with neutrophilia, and a significantly altered liver profile: 
aspartate aminotransferase 1896 U/L; alanine aminotransferase 640 U/L; lactate dehydrogenase 2499 U/L; alkaline phosphatase 230 U/L; 
total bilirubin 4.78 mg/dL.
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During his stay in ED, his blood lactate level increased from 5.1 to 10.2 mmol/L and C-reactive protein from 1.35 to 12.19 mg/dL. Procalcitonin 
was 83.86 ng/mL. Blood cultures were sent to the laboratory and empiric broad-spectrum antibiotics (piperacillin/tazobactam) were started.
Assuming a possible abdominal focus, we performed an abdominal computed tomography (CT) scan with contrast. It revealed a diffuse 
heterogeneous structure with hypodensity within the right lobe of the liver and two relatively extensive areas with gas, the largest of which 
was 93 mm in diameter. There was no evidence of abscess formation or other significant changes (Figs 1 and 2). This result, along with the 
liver profile alterations, led to the diagnosis of emphysematous hepatitis with acute liver failure. While still in ED, the patient developed 
severe metabolic acidosis and distributive shock requiring vasopressor support. Because of his condition and the lack of proven benefit of 
a surgical approach, including percutaneous drainage, he was admitted to the intensive care unit and supportive therapy was instituted.
Figure 1. CT scan of the abdomen in coronal view showing an extensive area 
with gas within the right lobe of the liver
Figure 2. CT scan of the abdomen with contrast in axial view showing two areas with gas 
within the right lobe of the liver
On the second day of admission, his clinical state deteriorated along with blood analysis; the antimicrobial spectrum was extended and he 
was commenced on vancomycin, metronidazole, and fluconazole. Despite these measures, his condition evolved to multiorgan failure and 
he died on the third day of admission. The decision for autopsy was deterred due to lack of consent. Blood cultures subsequently grew multi-
sensitive Escherichia coli. 
DISCUSSION
Emphysematous infections of the abdominal organs have long been recognized and are potentially life-threatening conditions. The presence 
of gas within the liver can be due to a variety of causes, often including liver abscesses, iatrogenic causes, and seldom infection by gas-
forming bacteria[1].
Emphysematous hepatitis is a rare condition characterized by replacement of hepatic parenchyma by gas often followed by a fulminant 
inflammation of the liver leading to acute liver failure, as seen in patients with risk factors such as diabetes mellitus and liver disease[1–4] 
or a recent history of abdominal surgery[2–5]. In contrast to the other cases reported, our patient had no recognizable risk factors. Gas 
formation might develop in the setting of gas-forming infection, high tissue glucose level, and impaired transportation of gas by vascular 
compromise. Mixed acid fermentation from tissue necrosis by bacteria produce nitrogen, hydrogen, carbon dioxide, and oxygen, resulting in 
gas accumulation[1]. In our patient, Escherichia coli was isolated, indicating that this was the microorganism responsible for the infection and 
the emphysematous infiltration of the liver. Clinical manifestations are usually subtle at the beginning and progress rapidly, as seen in other 
reported cases [1–5]. Our patient complained of fever and abdominal pain for 2 days and was admitted with altered mental status, rapidly 
progressing to septic shock. The diagnosis of emphysematous hepatitis requires abdominal imaging, preferably a contrast-enhanced CT 
European Journal
of Case Reports in
Internal Medicine
DOI: 10.12890/2020_001539 European Journal of Case Reports in Internal Medicine © EFIM 2020
scan. Gas within the liver is usually evident but pyogenic liver abscesses should be ruled out. 
Management of this condition usually involves parenteral broad-spectrum antibiotics and drainage of the collection. In all reported 
cases early broad-spectrum antibiotics were commenced but drainage was not always attempted either because it seemed futile[3] or the 
hemodynamic status of the patient did not permit it[4]. In our patient, drainage was not attempted because it seemed futile and the patient’s 
condition deteriorated so rapidly that the procedure could not be safely performed.
Emphysematous hepatitis continues to be difficult to manage and despite aggressive measures the condition progresses to a fatal outcome 
in the first days of admission, as seen in our case and other reported cases. We encourage the use of aggressive early therapeutic measures 
in patients with emphysematous hepatitis in order to control the infection.
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